Loading...
Targeted Opioid Receptor Antagonists in the Treatment of Alcohol Use Disorders
In 1994, the US Food and Drug Administration approved the μ-opioid receptor antagonist naltrexone to treat alcohol dependence. However, treatments requiring daily administration, such as naltrexone, are inconsistently adhered to in substance abusing populations, and constant medication exposure can...
Na minha lista:
| Udgivet i: | CNS Drugs |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4600601/ https://ncbi.nlm.nih.gov/pubmed/23881605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-013-0096-4 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|